News
Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.37 billion for the fourth quarter ended Oct. 31, 2019, up 6% year over year (core(1) growth of 4%).
On a GAAP basis
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is
Humana Honored for Hispanic Inclusion Efforts
Humana Inc. (NYSE: HUM) has again scored well in the HACR Corporate Inclusion Index, an annual survey by the Hispanic Association on Corporate Responsibility that measures companies’ business
Humana and Epione Health Team Up to Offer a Patient-Centered Experience for Humana Medicare Advantage Members in Oklahoma
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced it has collaborated with Epione Health of Oklahoma, LLC on a value-based agreement designed to offer a coordinated
ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting
ArQule, Inc. (Nasdaq: ARQL) today announced that final clinical data from the company-sponsored phase 1 study of ARQ 531 will be presented on December 9, 2019 at the 61st American Society of
The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion
The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines Company for $85 per share in an all-cash
SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the extension of the current marketing authorization of SOLIRIS®
SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the extension of the current marketing authorization of SOLIRIS®
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)
Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union.
The assay is CE-IVD–marked as an aid in
Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of
Humana Improves Health and Reduces $3.5 Billion in Health Care Costs through Medicare Advantage Value-Based Care Programs
Helping people living with multiple chronic conditions achieve their optimal whole-person health has been a strategic initiative for Humana Inc. (NYSE: HUM). Today, Humana announced that the
Agilent Announces Applications Open for LabCentral Golden Ticket
Agilent Technologies Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and
Agilent Technologies Increases Cash Dividend to 18 Cents Per Share
Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.
Evercore ISI HealthCONx
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.
Evercore ISI HealthCONx
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.
Evercore ISI HealthCONx
Humana and agilon health Expand Relationship, Announce Value-Based Agreements with Physician Groups
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that it has signed value-based care agreements with agilon health, which helps physicians and
Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology
Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields, including three oral presentations, will be featured at the 24th Annual Meeting of the Society for Neuro-Oncology
LivaNova to Restructure its Heart Valve Business Line and End Caisson Transcatheter Mitral Valve Replacement Program
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it is ending its Caisson Transcatheter Mitral Valve Replacement (TMVR) program and will
LivaNova restrukturiert sein Geschäftsgebiet Herzklappen und beendet das Programm zum Austausch von Mitralklappen mit Caisson-Transkathetern
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen der Medizintechnik und Innovation, gab heute bekannt, dass es sein Programm Caisson Transcatheter Mitral Valve Replacement (TMVR) beendet
Heat Biologics: Aktie explodiert - darauf ist jetzt zu achten!
Der Aktienkurs von Heat Biologics (WKN: A2JB4Y) erlebt derzeit ein wahres Auf und Ab. Wohin die Reise letztendlich geht, entscheiden die jetzt veröffentlichten Topline-Daten zur
Prothena: NBC-Bonusaktie marschiert +60% in 5 Wochen
Am 29. August stellten wir NBC-Mitgliedern die irische Prothena (WKN: A1KAVV) als Bonusaktie vor. Zu diesem Zeitpunkt hatte die Value-Perle unsere gewünschte Kaufzone bis 7,50 USD bereits
Humana and Hawaii Senior Medical Group Announce Agreement Expanding Value-Based Care for Humana Medicare Advantage Members in Hawaii
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced it has collaborated with Hawaii Senior Medical Group on a value-based agreement designed to offer a coordinated
Humana Pharmacy Wins Specialty Pharmacy Patient Choice Award, Two Years in a Row
The specialty pharmacy team of Humana Pharmacy, the mail-delivery pharmacy service of Humana Inc. (NYSE: HUM), received the Specialty Pharmacy Patient Choice Award in the PBM/Payer Specialty
LivaNova to Present at the Berenberg and Piper Jaffray Conferences
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Thad Huston, Chief Financial Officer, will participate in discussions at the Berenberg European Conference